Pinnacle Financial Group, Inc.’s Kiora Pharmaceuticals KPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding KPRX
Pinnacle Financial Group, Inc.'s KPRX Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Kiora Pharmaceuticals (KPRX) in Q3 2026: 250 shares worth $640. The stake represents ﹤0.01% of the portfolio and ranks #2131 among its holdings.
21 funds tracked by Wall St. Rank hold KPRX as of Q3 2026.
- Pinnacle Financial Group, Inc. held 250 shares of Kiora Pharmaceuticals worth $640 as of Q3 2026.
- Kiora Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Kiora Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2131 holding.
- 21 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.